ArticleMycopathologia2011
Aflatoxin B1 contamination of traditionally processed peanuts butter for human consumption in Sudan.
Article in Mycopathologia, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 46 citations in OpenAlex.
- Mycotoxins in food and agriculture: from occurrence to economic consequences.Archives of microbiology · 2025Review
- Mycotoxin contamination in the Arab world: Highlighting the main knowledge gaps and the current legislation.Mycotoxin research · 2024Review
- Evaluation of ELISA and immunoaffinity fluorometric analytical tools of four mycotoxins in various food categories.AMB Express · 2023Article
- Environmental Chemical Contaminants in Food: Review of a Global Problem.Journal of toxicology · 2019Review
- Engaging One Health for Non-Communicable Diseases in Africa: Perspective for Mycotoxins.Frontiers in public health · 2017Review
- Review
- An overview on mycotoxin contamination of foods in Africa.The Journal of veterinary medical science · 2014Review
- Aflatoxin M₁ in breast milk of nursing Sudanese mothers.Mycotoxin research · 2012Article
- The paradox of nutrition-related diseases in the Arab countries: the need for action.International journal of environmental research and public health · 2011Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A survey was carried out to detect the presence of aflatoxin B(1) in 60 duplicated samples (120 samples) of peanuts butter purchased from the local markets and other traditionally prepared and distributed by the street sellers in Khartoum state, Sudan. AflaTest-P affinity column was used to extract the toxin from the samples, and the concentration was measured by calibrated Vicam fluorometer. Aflatoxin B(1) was detected at variable levels in 100% of the screened samples. Traditionally prepared samples showed the highest incidence of aflatoxin B(1) which is above the internationally regulated tolerance levels (5-20 ppb). The means and the ranges of the aflatoxin B(1) recovered were as follows: 63.9 ppb (29-128 ppb), 54.5 ppb (21-131 ppb) and 101 ppb (17-170 ppb) for samples collected from Khartoum, Khartoum North and Omdurman areas, respectively. Samples from retail stores presented relatively low aflatoxin B(1) incidences 14.5 ppb (1-57 ppb), but only 30% of the samples revealed aflatoxin level below 10 ppb. Laboratory segregated and carefully prepared butter from good grade nuts showed the lowest levels of this toxin (3.3 ppb; 2-6 ppb). The results showed that peanuts butter prepared by the street sellers and distributed by the retail stores are evidently hazardous to human health. There is therefore urgent need for strong form of quality control measures and public awareness. The use of excellent grade peanuts and care during processing and storage are priority.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.